GO-2

N/A

Report date: 2023/01/07 19:50:57

Base Information

Drug NameGO-2

Drug Alias NameGO-2

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibody

Mechanisms of ActionAntibody-dependent cell-mediated cytotoxicity (ADCC) effectsT lymphocytes stimulantsMucin inhibitors

TargetsMucin

Therapy Area/IndicationsOvarian NeoplasmsColorectal NeoplasmsBreast Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesGo Therapeutics Inc

China Registration ClassN/A

Develop Information

Active CompaniesGo Therapeutics Inc

Inactive CompaniesN/A

Active IndicationsOvarian NeoplasmsColorectal NeoplasmsBreast Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A